As a disease of the genome, cancer development has a clear Mendelian component, demonstrated by several famous genes such as BRCA1 and BRCA2 in breast cancer risk (Smithers 1948; Murthy and Muggia 2019). The gene discussed is BRCA2; the disease is breast carcinoma.